Positive results emerge from AEGEAN phase 3 trial for patients with resectable non-small cell lung cancer

Collaboration will concentrate on launching and running studies within medical dermatology

Updated Date: Thu, 02 Mar 2023 00:00:00 EST

Congenital diaphragmatic hernia is one of the deadliest birth defects. To better understand and treat this condition in […]

The constant evolution of new COVID-19 variants makes it critical for clinicians to have multiple therapies in their […]

FlyPharma Europe chose Vienna for its latest conference due to the growing presence of Austrian biotechnology and pharmaceutical […]

Move represents the latest phase of preparation for the opening of MSD’s new UK Discovery Centre

The partnership will concentrate on the development of two investigational antibodies

Updated Date: Wed, 01 Mar 2023 00:00:00 EST

Updated Date: Wed, 01 Mar 2023 00:00:00 EST